Migraine is a genetic, neurological disease that affects nearly 48 million people in the United States – nearly 1 in 5 patients in your practice! Migraine has significantly greater prevalence than other common conditions managed through your practice and represents an opportunity for ECPs to serve in the frontline of care for patients living with this debilitating condition.

 

Discover how Avulux is elevating patient care with its patented, clinically proven lenses for patients living with migraine and light sensitivity.